Intrabony Defect
5
1
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Flapless Periodontal Regeneration Using Hyaluronic Acid Versus Enamel Matrix Derivative
Treatment of Intrabony Defect in Patient With Periodontitis Stage III by Using I-PRF and Xenograft
RGD With Minimally Invasive Non-Surgical Technique in Treatment of Periodontal Intrabony Defect
Chitosan Nano-hydroxyapatite Hydrogel in Non-Surgical Treatment of Intrabony Defect
Effect of Autogenous Demineralized Dentin as a Bone Graft Substitute in Management of Periodontal Intrabony Defects